cerca CERCA
Mercoledì 21 Aprile 2021
Aggiornato: 06:58
Temi caldi

CHIMICA E FARMACEUTICA

30° Congresso "European Respiratory Society"

Al Simposio "Quale obiettivo per proteggere e preservare la salute polmonare?" si parla della gestione dei pazienti affetti da malattie polmonari croniche e di nuove evidenze nella ricerca scientifica su COVID-19.

Executive from Yuyu Pharma Receives Presidential Commendation for Gender Equality Employment

SEOUL, South Korea, Sept. 4, 2020 /PRNewswire/ -- Eugene Baik, Head of Production at Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220), received the Presidential Commendation for contributions in leading the realization of gender equality employment. The award was given at the 2020 Gender Equality Award Ceremony held on the 31st at the Government's Seong Convention Center.

Pluristem amplia il proprio programma COVID-19 all'Europa, riceve l'autorizzazione del PEI per iniziare lo studio di fase II in Germania

HAIFA, Israele, 12 agosto 2020 /PRNewswire/ -- Pluristem Therapeutics Inc.  (Nasdaq: PSTI) (TASE: PSTI), un'azienda leader nel settore della medicina rigenerativa che sviluppa una piattaforma di nuovi prodotti biologici terapeutici, ha annunciato oggi che l'agenzia tedesca di regolamentazione sanitaria, il Paul Ehrlich Institute (PEI), ha approvato il protocollo clinico di fase II dell'azienda per il suo studio intitolato "Uno studio di fase II randomizzato, controllato, multicentrico, a gruppi p...

THRIVE II: This Is What It Takes releases trailer August 8th in 15 languages for sequel to one of the top watched documentaries of all time

LOS ANGELES, Aug. 8, 2020 /PRNewswire/ -- THRIVE: What on Earth Will it Take? is one of the most widely viewed documentaries in history with over 90 million views across 27 different languages. Released in November 2011, the unconventional documentary lifted the veil on what is truly happening in our world by uncovering the global consolidation of power in nearly every aspect of our lives.

Caprion-HistoGeneX and Viroclinics-DDL announce a strategic partnership to offer integrated, complementary services to advance infectious disease research and COVID-19 therapeutic development

Caprion-HistoGeneX, a specialized CRO providing immunology, proteomics, histopathology and genomics services, and Viroclinics-DDL, a provider of preclinical and clinical trial services for vaccine, antiviral, and diagnostic development, are pleased to announce a new partnership that will offer global, integrated services to support discovery and development of vaccines and antiviral therapies.

WuXi Vaccines Appoints Mr. Jian Dong as Chief Executive Officer

SHANGHAI and DUNDALK, Ireland, Aug. 6, 2020 /PRNewswire/ -- WuXi Vaccines, a global leading company with world-class vaccine contract development and manufacturing organization (CDMO) capabilities, is pleased to announce the appointment of Mr. Jian Dong as Chief Executive Officer (CEO). WuXi Vaccines is a joint venture established between WuXi Biologics and Shanghai-based Hile Bio-Technology.

ora in
Prima pagina
Tag più usati
in questa pagina

change in emea region

executive

leadership

leadership change

partner di canale

prodotti imdsoft

servizi metavision

sistema informativo

articoli
in Evidenza